Fate Therapeutics
FATE
#7766
Rank
NZ$0.40 B
Marketcap
$3.54
Share price
-6.76%
Change (1 day)
-12.43%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$3.60

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.71. In 2022 the company made an earnings per share (EPS) of -$4.98 a decrease over its 2021 EPS that were of -$3.82.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.60-27.65%
2022-$4.9830.49%
2021-$3.827.21%
2020-$3.5645.45%
2019-$2.4519.17%
2018-$2.0517.65%
2017-$1.75-3.77%
2016-$1.81-12.4%
2015-$2.07-3.97%
2014-$2.16-2.09%
2013-$2.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$13.40 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.50-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$14.81 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.31 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.36-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA